Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Zeitlin

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2000
Cystic fibrosis gene therapy trials and tribulationsP L Zeitlin
Anesthesiology|September 1, 1994
Burns from warming devices in anesthesia--1910G L Zeitlin
The Journal of Pediatrics|September 20, 2001
Advances in the diagnosis of cystic fibrosis in infantsP L Zeitlin
The Journal of Clinical Investigation|February 18, 1999
Novel pharmacologic therapies for cystic fibrosisP L Zeitlin
Expert Opinion on Emerging Drugs|December 10, 2003
Emerging drug treatments for cystic fibrosisPamela L Zeitlin
The Journal of Clinical Investigation|November 27, 2008
Cystic fibrosis and estrogens: a perfect stormPamela L Zeitlin
Respiration; International Review of Thoracic Diseases|August 15, 2000
Future pharmacological treatment of cystic fibrosisP L Zeitlin
Anaesthesia|May 1, 1989
Possible decrease in mortality associated with anaesthesia. A comparison of two time periods in Massachusetts, USA. Closed Claims Study CommitteeG L Zeitlin
Molecular Pharmacology|August 1, 2006
Is it go or NO go for S-nitrosylation modification-based therapies of cystic fibrosis transmembrane regulator trafficking?Pamela L Zeitlin
American Journal of Physiology. Cell Physiology|June 26, 2009
Pseudomonas aeruginosa: can studies in engineered cells tell us why is it such a problem in people with cystic fibrosis? Focus on "Cystic fibrosis transmembrane conductance regulator and caveolin-1 regulate epithelial cell internalization of Pseudomonas aeruginosa"Pamela L Zeitlin
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2000
Cystic fibrosis gene therapy trials and tribulationsP L Zeitlin
Anesthesiology|September 1, 1994
Burns from warming devices in anesthesia--1910G L Zeitlin
The Journal of Pediatrics|September 20, 2001
Advances in the diagnosis of cystic fibrosis in infantsP L Zeitlin
The Journal of Clinical Investigation|February 18, 1999
Novel pharmacologic therapies for cystic fibrosisP L Zeitlin
Expert Opinion on Emerging Drugs|December 10, 2003
Emerging drug treatments for cystic fibrosisPamela L Zeitlin
The Journal of Clinical Investigation|November 27, 2008
Cystic fibrosis and estrogens: a perfect stormPamela L Zeitlin
Respiration; International Review of Thoracic Diseases|August 15, 2000
Future pharmacological treatment of cystic fibrosisP L Zeitlin
Anaesthesia|May 1, 1989
Possible decrease in mortality associated with anaesthesia. A comparison of two time periods in Massachusetts, USA. Closed Claims Study CommitteeG L Zeitlin
Molecular Pharmacology|August 1, 2006
Is it go or NO go for S-nitrosylation modification-based therapies of cystic fibrosis transmembrane regulator trafficking?Pamela L Zeitlin
American Journal of Physiology. Cell Physiology|June 26, 2009
Pseudomonas aeruginosa: can studies in engineered cells tell us why is it such a problem in people with cystic fibrosis? Focus on "Cystic fibrosis transmembrane conductance regulator and caveolin-1 regulate epithelial cell internalization of Pseudomonas aeruginosa"Pamela L Zeitlin
Pageof 17